|
Virtual Patient: Asthma in the Older Adult
This patient simulation requires an evaluation and creation of a treatment plan for an older adult (>65 years old) with asthma. The case involves identification of differences and similarities between asthma and COPD in older adults and consideration of medications and co-morbid conditions that may complicate the management of asthma in this population. A summary of the literature supporting best practices in asthma care in the older adult will be provided. |
|
|
Virtual Patient: Rhinitis in the Older Adult
This patient simulation involves the clinical presentation, diagnostic evaluation, and clinical management of an older adult (>65 years old) with rhinitis. The course will review the unique features and potential challenges in diagnosis and treatment of rhinitis in this age group and the identification of medications that affect rhinitis in this population. A mentor will provide feedback throughout the simulation. |
|
Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia
STATEMENT OF NEED
Waldenstrom macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by lymphoplasmacytic bone marrow infiltration and the presence of serum monoclonal IgM. With an estimated 1,500 new cases reported in the United States annually, the malignancy accounts for 2% of non-Hodgkin lymphomas. Unfortunately, WM is considered incurable with available therapies. Patients with low- and intermediate-risk disease have 5-year survival rates of 87% and 68%, respective... |
|
|
Optimizing Treatment Experiences in Castration-Resistant Prostate Cancer
STATEMENT OF NEED
Prostate cancer is the most common tumor type in men in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Nonmetastatic castration-resistant prostate canc... |
|
The New Paradigm in Atopic Dermatitis Treatment
Steven Feldman, MD, PhD, and Jonathan Silverberg, MD, PhD, MPH, provide their clinical insights into the burden of disease experienced by persons with atopic dermatitis and strategies for management. They discuss how improved understanding of pathophysiologic mechanisms has led to the availability of new topical and systemic therapies that, when integrated with other therapies, can reduce patients’ disease burden. They also discuss 6 medications in late-stage development for atopic dermatitis. |
|
|
Food Allergy: From Primary Prevention to Treatment and Intervention
This live course will allow participants to increase their knowledge and skills related to the diagnosis and management of food allergic patients. It will highlight the latest evidence related to food allergies, and will include a combination of lectures, small group discussions, and hands-on training to prepare participants to return to their practices prepared to provide optimal care to these patients.
Cost varies by attendee type. See the website for details. |
|
|
Implementing New Data and Evolving Standards in Metastatic Triple-Negative Breast Cancer
STATEMENT OF NEED
Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population. About 20% of patients have invasive triple-negative breast cancer (TNBC), which is defined as having estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) negativity. Whereas therapies targeting these receptors have demonstrated efficacy in other breast cancer ... |
|
|
Challenges and Opportunities in Metastatic Gastric Cancer
STATEMENT OF NEED
Gastric cancer is the third leading cause of cancer-related death worldwide. In the US, an estimated 27,510 new cases of gastric cancer are diagnosed annually, and 11,140 people die of the disease. Despite advances in prevention, diagnosis, and treatment, due to the molecular heterogeneity of gastric cancer, prognosis remains poor. The 5-year survival rate for all stages is 31%, with only 5% of those diagnosed with distant-stage disease surviving longer than 5 years. Given... |
|
Emerging Concepts in the Recognition and Management of SLE
Michelle Petri, MD, MPH, and Daniel J. Wallace, MD, FACP, MACR, provide their experience and insight into the diagnosis and management of systemic lupus erythematosus (SLE), with perspectives for both general practitioners and rheumatologists.
CONTENT AREAS
• Signs and symptoms
• Diagnosis
• Organ-threatening disease
• Non-organ-threatening disease
• Treatment goals
• Adherence and monitoring
• Prognosis
• Research topics
• Clinical trials
|
|
|
Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies
STATEMENT OF NEED
Although the clinical outcomes of patients with B-cell malignancies such as diffuse large B-cell lymphoma and B-cell acute lymphoblastic leukemia have improved during the past decade, many continue to develop relapsed or refractory disease, representing a significant cause of morbidity and mortality. CAR T-cell therapy has been shown to produce significant antitumor responses in these patients, for whom treatment options are limited. However, CAR T-cell therapy is associat... |
|
|
Challenges and Opportunities in Hodgkin Lymphoma
STATEMENT OF NEED
Hodgkin lymphoma (HL) is a rare malignancy involving the lymph nodes and lymphatic system, with 8,500 new cases diagnosed and accounting for 1,050 deaths each year in the United States. In contrast with other cancers whose risk increases with age, the risk for HL increases in patients between 15 and 30 years of age, decreases during middle age, and is followed by another peak in adults older than 55. There are 2 main types of HL: classical HL, which accounts for 95% of cas... |
|
|
Current Trends in the Management of Castration-Resistant Prostate Cancer
STATEMENT OF NEED
Prostate cancer is the most common tumor type in men in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Nonmetastatic castration-resistant prostate canc... |
|
Advancing Knowledge to Practice: Optimizing Severe Asthma Care in the Age of Biologics
Michael E. Wechsler, MD and Jonathan Corren, MD, discuss the clinical differentiation of asthma subgroups and the characterization of inflammatory pathways, as well as biomarkers for severe asthma and their application to clinical practice. They review the latest treatment options, focusing on new biologic-based targeted therapies, differentiating between biologic agents and their mechanism of action, as well as the latest safety and efficacy data of targeted therapy. They also discuss optimal... |
|
|
Current Challenges and New Opportunities in Follicular Lymphoma
STATEMENT OF NEED
Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab... |
|
|
Latest Development and Expert Outlook of Management of Psoriatic Arthritis
Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal, disabling disease,
commonly associated with skin psoriasis, and estimated to affect up to 42% of the
approximately 7.5 million people in the United States with psoriasis. There remains an
ongoing challenge among clinicians to diagnose and treat patients, as well as to stay abreast
of optimal treatment strategies. In this educational program, the latest biologic treatment
recommendations are reviewed, as well as clinica... |
|
|
The Why and How for Combination Basal Insulin + GLP-1RA Therapy in Type 2 Diabetes
John Anderson, MD, and Vivian Fonseca, MD, provide their clinical insights into the rapidly evolving use of combined basal insulin and glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy for the treatment of patients with type 2 diabetes mellitus (T2DM).
CONTENT AREAS
• Unmet needs
• Experience with basal insulin/GLP-1RA
• FRC basal insulin/GLP-1RAs
• Insulin degludec/liraglutide (DUAL)
• Insulin glargine/lixisenatide (LixiLan-L, -O)
• Using FRC basal insulin/GLP-1RAs... |
|
|
Nursing Strategies to Optimize Treatment Experiences in Hormone-Receptor Positive, HER2-Negative Metastatic Breast Cancer
STATEMENT OF NEED
Breast cancer accounts for nearly 30% of cancer diagnoses among women in the United States, and is the second-leading cause of cancer death in this population. Although many women benefit from regular screening as well as earlier and improved treatment, approximately 10% present with metastatic disease, and 30% with no initial lymph node involvement eventually develop metastatic disease. Women with metastatic breast cancer (MBC) have a poorer prognosis than the overall pop... |
|
|
Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy
STATEMENT OF NEED
There are an estimated 13,240 new cases of cervical cancer in the United States each year, and 4,170 people die of the disease. Due to screening and heightened awareness, deaths have declined during the past few decades. However, the malignancy continues to be a global health concern and is considered an epidemic in parts of the world. A significant proportion of patients develop advanced disease, which is rarely curable with available therapies, and treatment is often lim... |
|
|
Inject-Safe Barrier Bandages
This 1-minute (non-accredited) short-course provides training on Inject-Safe Barrier Bandages and how they prevent the transfer of bloodborne pathogens. Inject-Safe Barrier bandages self-seal to contain bleeding following an injection or immunization protecting the patient and healthcare provider. They meet the OSHA Bloodborne Pathogen Standard's definition on "Engineering Control" to reduce employee exposure. |
|
|
An Introduction to Pharmacogenomics (PGx)
This 15-minute (non-accredited) short-course provides a brief introduction to the study of pharmacogenomics (PGx) and its importance in pharmacotherapy. Presented by Dr. David Kisor, PharmD, FCP, Manchester University. |
|
|
Evaluating 503B Outsourcing Providers
This 10-minute course (non-accredited) provided by LDT Health Solutions serves to develop an understanding of the 2017 regulatory landscape as it relates to evaluating 503B outsourcing providers. This course is recommended to anyone currently in process of assessing 503B services. Content is provided by LDT Health Solutions: Lou Diorio RPh, FaPhA and Dave Thomas, RPh, MBA. |
|
|
Spanish for Pharmacists
A comprehensive course for pharmacists and pharmacy technicians to learn basic Spanish language skills to improve their patient counseling and communication skills in a pharmacy. Spanish for Pharmacists provides education on pharmacy "one liners", tips to communicate with Spanish speaking patients, alphabet, punctuation, general vocabulary, numbers, colors, and more! |
|
|
Cardinal Health: The Innovative Delivery Solutions Group | An Overview
This short course provides an overview of the various products, services, and career opportunities available with Cardinal Health Innovative Delivery Solutions or IDS. The course contains information on pharmacy management, remote order entry, and telepharmacy. As well as insights right from the Talent Acquisition Manager at Cardinal Health IDS. |
|
|
Actemra (tocilizumab) | Administration
This 4-minute (non-accredited) short-course on Actemra (tocilizumab) administration provides patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: how to administer the medication and proper technique. |
|
|
Benlysta (belimumab) | Patient Counseling & Communication
A 3-minute (non-accredited) short-course on Benlysta (belimumab) | This course provides patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: drug indications, dosing, and common side effects. |
|
|
Carvedilol | Patient Counseling & Communication Skills
A 3-minute (non-accredited) short-course on Carvedilol | This course provides patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: drug indications, dosing, and common side effects. |
|
|
Insulin U-100 Vials | Administration
A 3-minute (non-accredited) short-course on Insulin U-100 Vials Administration. Providing patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: how to administer the medication and proper technique. |
|
|
CareerEDGE | Interview Preparation & Advice provided by Pharmacy Recruiters
This 33-minute course (non-accredited) provides interview preparation and career advice for pharmacy students and pharmacy tech students provided by actual pharmacy recruiters throughout various practice settings (community, health system, academia, and pharma)! Learn tips on what to do in an interview, what not to do, qualities they are looking for, commonly asked questions, and more. |
|
|
340B Drug Pricing Discount Program | An Overview
This 1-minute (non-accredited) short-course provides an overview of the 340B Drug Pricing Discount Program. It is a ten minute, need-to-know overview of this topic for pharmacy students, tech students, and professionals to gain a working knowledge of 340B - who developed the program, which health systems qualify for the program, and how it impacts patients. |
|
|
The Pharmacy Experience | A Comprehensive Overview of the Pharmacy Market
A ten-hour, 68 module course (non-accredited) serving as an introduction to the pharmacy market and perfect for pharmacy students, pharmacy tech students, professionals new to the pharmacy market, and practitioners. The Pharmacy Experience course explores critical need-to-know subjects, practice settings, roles in a pharmacy, services, and pharmacy technology. |
|
|
Diagnosis and Natural History of Peanut Allergy
This is an interactive course that provides information about the diagnosis and natural history of peanut allergy. We will cover a variety of topics that are important when evaluating a patient for peanut allergy, such as details about testing and interpreting the results. We'll also cover pertinent information about persistence and resolution of peanut allergy. |
|
|
Virtual Patient: Prescribing and Adjusting Doses for Effective AIT Treatment
In this simulation, you will see a patient who hopes immunotherapy may treat her long-standing allergy symptoms. You will be asked to provide thorough explanations of different AIT options and their risks and then write an accurate prescription based on the diagnostic tests you have run. You will monitor her progress over a period of time and make adjustments to her immunotherapy doses as needed. Just like in your clinic, you will want to make the correct decisions so that the treatments you i... |
|
|
Virtual Patient: Adult Male with Reaction to Flying Hymenoptera Sting
This patient simulation involves an adult male who had a severe reaction to a flying hymenoptera sting. Based on the clinical history and test results, the learner will choose the best way to treat the patient with immunotherapy. The learner will answer specific questions that explain the immunotherapy treatment, including risks, intervals, duration, and possibility of relapse to the patient. The learner will receive feedback for each decision that is made, and numerous references that discuss... |
|
|
Virtual Patient: Young Child with Allergy to Grass Pollen
This course provides a case simulation that involves evaluation and management of a young child with seasonal allergic rhinitis with allergen immunotherapy (AIT). The benefits and risks of AIT in general in the context of a young child will be reviewed, and a summary of AIT literature supporting best practices will be provided.
|
|
|
2018 Virtual Joint Congress
The 2018 Virtual Joint Congress (Virtual Annual Meeting) provides you the opportunity to expand your knowledge and clinical skills, and maintain your certification – on your time, at your convenience. Please note the recordings are not live at the Joint Congress.
The Virtual Joint Congress includes recordings of over 75 sessions from the live 2018 Virtual Joint Congress, including:
•Presentation slides along with video and audio for the Plenary and Keynote sessions
•Presentation sl... |
|
|
Non-IgE Adverse Reactions to Foods: Improving Diagnosis and Treatment
This interactive course aims to improve the diagnosis and treatment of patients suffering from non-IgE mediated food allergy.
It provides information about the presentation, triggers, and diagnostic tools to help allergy professionals more accurately differentiate between non-IgE mediated food allergy and food intolerance.
The course also gives a lengthy discussion about management strategies and answers to common patient questions. |
|
|
Virtual Patients: Is Allergen Immunotherapy the Right Choice for Your Patient?
In these patient simulations, you will assess the appropriateness of allergen immunotherapy (AIT) for patients with particular health characteristics.
Using evidence from the literature, you will determine if it is likely that immunotherapy will be safe and effective in various clinical scenarios. In some cases, you may need to help your patients gain control of other symptoms before starting AIT.
You will differentiate the appropriateness of subcutaneous versus sublingual immunotherap... |
|
|
Eosinophilic Esophagitis from the Allergist's Perspective
This is an interactive course that aims to ensure that allergists and allied health providers understand Eosinophilic Esophagitis (EoE). The course discusses the characteristics, symptoms, and triggers of EoE and explains how it is different from other allergic reaction diseases. Diagnostic and management strategies, including diets and medications, are also covered at length. |
|
|
Preventing Residual Neuromuscular Blockade and Ensuring Complete Recovery: A Discussion and Demonstration Using Simulation
Upon completion of this activity, participants will have improved their ability to:
1. Identify patients at risk for residual neuromuscular blockade (RNMB)
2. Appraise the roles of subjective and objective train-of-four monitoring in reducing the risk of RNMB
3. Employ an appropriate RNMB reversal agent and dose in patients with comorbid conditions
4. Discuss strategies to improve perioperative patient safety for moderate and deep neuromuscular blockade |
|
|
Fact or Fiction? Test Your Knowledge on Residual and Treatment-Emergent Symptoms in Major Depressive Disorder
Although major depressive disorder (MDD) has a profound impact on individuals, families, and society, it remains undertreated. There are currently more than 4 million US adults who are inadequately treated for MDD. Numerous studies show that antidepressant therapies are superior to placebo, but most adults with MDD do not achieve an adequate response with first-line pharmacotherapy. Inadequate response to antidepressant therapy is associated with greater medical morbidity, more hospitalization... |
|
|
Validation and Counseling of Prescriptions for Controlled Substances and Opioids
This program will identify the latest prescription drug diversion trends that practicing pharmacists need to be aware of. The program will describe the laws regarding the validation of controlled substance prescriptions for the state of Florida. It will describe tips when reviewing a state prescription drug monitoring program report. It will also discuss comment red flags of prescription drugs diversion by patients and prescribers used to obtain prescriptions for controlled substance for abuse... |
|
|
Validation and Counseling of Prescriptions for Controlled Substances and Opioids
This program will identify the latest prescription drug diversion trends that practicing pharmacists need to be aware of. The program will describe the laws regarding the validation of controlled substance prescriptions for the state of Florida. It will describe tips when reviewing a state prescription drug monitoring program report. It will also discuss comment red flags of prescription drugs diversion by patients and prescribers used to obtain prescriptions for controlled substance for abuse... |
|
|
Pain Management Specialty Pharmacist: Module 1 - Pain Management in the Opioid Crisis
This session is part of the Pain Management Specialty Pharmacist series. It explores the effective management of pain within the context of the current opioid crisis. This session examines the concept of addiction and explores the correlation between the rate of overdose deaths and the rate of prescribing of opioid medications. In addition, the introduction of abuse-deterrent formulations is explored as a method of reducing prescription drug abuse. Morphine milligram equivalent dosing is d... |
|
|
Prebiotics, Probiotics, and Synbiotics, OH MY! Better Living Through Microorganisms
Community pharmacists commonly encounter questions about probiotics while their shelves are exploding with different products and many do not know which products are better to recommend. |
|
|
A Makeover for Hepatitis B
In November of 2017 HEPLISAV-B was approved for the prevention of hepatitis B. HePLISAV-B is a two-dose vaccine administered 4 weeks apart. It will be important for health care providers to be aware of these new options. Health care providers will need to understand how HEPLISAV-B compares to other commercially available hepatitis B vaccines. In addition, numerous limitations exist with the oral antiviral medications currently used to treat patients chronically infected with hepatitis B. New r... |
|
|
Fundamental EYEdeas: Ophthalmic Counseling Points for Pharmacists
This activity will review key counseling points that pharmacists encounter daily, especially when caring for patients with diabetes. We will discuss diabetic retinopathy and importance of routine eye exams. This activity will also include treatment of herpetic eye disease as well as possible ocular complications with the misuse of topical steroids. After completion of this activity, participants will have a greater confidence counseling patients regarding common general treatment concepts, inc... |
|
|
A New Hope in the Prevention of Shingles
Shingles is cause by a reactivation of latent varicella-zoster (VZV) virus. Risk of reactivation is a reality in more than 90% of adults who have been infected by VZV. Shingles can cause considerable pain and most notably can cause postherpetic neuralgia as a complication. Zostavax was recommended to prevent shingles in individuals over the age of 50 but was 50% effective in preventing VZV reactivation. Shingrix was approved by the FDA in October 2017. Shingrix has been shown to have an effica... |
|
|
Over the Counter Medications - What Can I Give My Child?
Parents want to help their children feel better when they are sick. They end up standing in front of the shelves and shelves of over the counter medications and staring at the many different options. It is difficult to determine which medication, if any, will be helpful. They often seek out advice from the pharmacy counter. Pharmacy staff need to be knowledgeable with the dosages and use of over the counter medication in order to best help these parents.
|
|
|
Wading Through the Alerts: The Top Drug Interactions You Need to Know
Last year, the Chicago Tribune ran a two part investigative series finding that most community pharmacists missed most drug interactions presented to them. Naturally, pharmacies and pharmacy technicians everywhere thought the same could be done in their city, and felt vulnerable in a sea of drug interaction alerts. This course presents the most common and serious drug interactions to be aware of, and the clinical implications of each.
|
|
|
PRS 103.1: New Drug Approval Process
Why does it seem that regulators focus solely on pharmacists when drug regulations are enforced? Why do so many nitpicky rules mandate or prohibit specific activities by pharmacists? How can regulators be shown that advances in pharmacy are impeded by outdated regulations? This introductory class will address these challenging questions. It will explain the foundation of legal requirements for pharmacists and pharmacies. It will describe how regulators think and work, and how pharmacists can a... |
|